Related Experiment Video
Updated: Sep 15, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
NOACs for VTE prevention in patients with lower limb fracture: a systematic review and meta-analysis
Bingbing Wu1, Lili Sun1, Wenying Wu1
1Department of Nursing, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, 1th Shangcheng Avenue, Yiwu, Zhejiang Province, 322000, China.
Background:
Novel oral anticoagulants (NOACs), including rivaroxaban, apixaban, edoxaban and dabigatran, are increasingly used for orthopaedic surgery patients. The aim of this study was to evaluate the efficacy and safety of NOACs in preventing venous thromboembolism (VTE) among patients with lower limb fractures.
Materials And Methods:
This meta-analysis included randomized controlled trials (RCTs). The PubMed, Embase, Cochrane Library, and Web of Science databases were comprehensively searched from inception to November 27, 2024. We evaluated the risk of bias via the Cochrane Risk of Bias Tool 2.0 (RoB 2.0). The efficacy outcomes focused on VTE, deep vein thrombosis (DVT), and pulmonary embolism (PE), and the safety outcomes focused on major bleeding events. Two researchers screened the literature on the basis of the inclusion and exclusion criteria, evaluated the quality of the included studies, extracted the data, and conducted a meta-analysis using RevMan 5.4.1.
Results:
The systematic search yielded 2,873 unique citations after deduplication. Ultimately, five RCTs involving 4,092 participants (2,066 participants in the NOAC group (rivaroxaban and edoxaban) and 2,026 participants in the LMWH group) were included. Pooled analysis revealed that NOACs reduced the incidence rate of DVT [OR = 0.48, 95% CI (0.23-0.97), P = 0.04; I²=10%]. However, there was no significant difference in the incidence of VTE [OR = 0.42, 95% CI (0.16-1.11), P = 0.08; I²=34%], PE [OR = 0.33, 95% CI (0.05-2.08), P = 0.24; I²=0%] or major bleeding [OR = 1.01, 95% CI (0.57-1.77), P = 0.98; I²=0%] between the LMWH group and the NOACs group.
Conclusions:
Compared with LMWH, NOACs were associated with a lower risk of DVT in patients with lower limb fractures, although there was no statistically significant difference in preventing VTE, PE and major bleeding.
Clinical Trail Number:
No. CRD42024619453.
Insights
Novel oral anticoagulants (NOACs) show a reduced risk of deep vein thrombosis (DVT) in patients with lower limb fractures compared to low molecular weight heparin (LMWH). However, no significant differences were found for overall venous thromboembolism (VTE), pulmonary embolism (PE), or major bleeding events.
Area of Science:
- Orthopaedic Surgery
- Pharmacology
- Vascular Medicine
Background:
- Novel oral anticoagulants (NOACs) are increasingly prescribed for patients undergoing orthopaedic surgery.
- Venous thromboembolism (VTE) is a significant risk for patients with lower limb fractures.
Purpose of the Study:
- To evaluate the efficacy and safety of NOACs in preventing VTE in patients with lower limb fractures.
- To compare NOACs against low molecular weight heparin (LMWH) in this patient population.
Main Methods:
- A meta-analysis of randomized controlled trials (RCTs) was conducted.
- Literature search performed across PubMed, Embase, Cochrane Library, and Web of Science databases up to November 27, 2024.
- Risk of bias assessed using Cochrane Risk of Bias Tool 2.0; data analyzed using RevMan 5.4.1.
Main Results:
- Five RCTs with 4,092 participants were included.
- NOACs significantly reduced the incidence of deep vein thrombosis (DVT) (OR=0.48, P=0.04).
- No significant differences observed for VTE, pulmonary embolism (PE), or major bleeding events.
Conclusions:
- NOACs demonstrate a potential benefit in reducing DVT risk for lower limb fracture patients.
- Further research may be needed to confirm efficacy in preventing overall VTE and PE, and to fully assess safety profiles compared to LMWH.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

